CpG deamination creates transcription factor-binding sites with high efficiency

Genome Biology and Evolution

Volumn 3, Issue 1, 2011, Pages 1304-1311

  Zemojtel, Tomasz ^a   Kiebasa, Szymon M ^a   Arndt, Peter F ^a   Behrens, Sarah ^a   Bourque, Guillaume ^b   Vingron, Martin ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Alu transposon; CpG deamination; CpG methylation; Evolution of gene regulatory elements; Evolution of transcription factor binding sites

Indexed keywords

DNA; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BINDING SITE; CHEMISTRY; CPG ISLAND; DEAMINATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; MOLECULAR EVOLUTION; MUTATION; PAN TROGLODYTES; PROMOTER REGION;

ANIMALS; BINDING SITES; CPG ISLANDS; DEAMINATION; DNA; EVOLUTION, MOLECULAR; GENE REGULATORY NETWORKS; HUMANS; MUTATION; PAN TROGLODYTES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 84858018851     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evr107     Document Type: Article

References (27)

1. Arndt PF, Hwa T. 2005. Identification and measurement of neighbor-dependent nucleotide substitution processes. Bioinformatics 21:2322-2328. (Pubitemid 40731586)
2. Bourque G. 2009. Transposable elements in gene regulation and in the evolution of vertebrate genomes. Curr Opin Genet Dev. 19:607-612.
3. Celniker SE, et al. 2009. Unlocking the secrets of the genome. Nature 459:927-930.
4. Cichocki F, et al. 2009. The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element. Blood 113:3245-3253.
5. Demars J, et al. 2010. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet. 19:803-814.
6. Dermitzakis ET, Clark AG. 2002. Evolution of transcription factor binding sites in mammalian gene regulatory regions: conservation and turnover. Mol Biol Evol. 19:1114-1121. (Pubitemid 34743235)
7. Duret L, Arndt PF. 2008. The impact of recombination on nucleotide substitutions in the human genome. PLoS Genet. 4:e1000071.
8. Feinberg AP, Irizarry RA. 2010. Evolution in health and medicine Sackler colloquium: stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc Natl Acad Sci U S A. 107(Suppl 1):1757-1764.
9. Galaktionov K, Chen X, Beach D. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517. (Pubitemid 26260686)
10. Horvath MM, Wang X, Resnick MA, Bell DA. 2007. Divergent evolution of human p53 binding sites: cell cycle versus apoptosis. PLoS Genet. 3:e127.
11. Kasowski M, et al. 2010. Variation in transcription factor binding among humans. Science 328:232-235.
12. Kerkel K, et al. 2008. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methyla-tion. Nat Genet. 40:904-908.
13. Kim TH, et al. 2007. Analysis of the vertebrate insulator protein Ctcf-binding sites in the human genome. Cell 128:1231-1245. (Pubitemid 46427876)
14. Kunarso G, et al. 2010. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet. 42:631-634.
15. Odom DT, et al. 2007. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat Genet. 39:730-732. (Pubitemid 46848594)
16. Perini G, Diolaiti D, Porro A, Della Valle G. 2005. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci U S A. 102:12117-12122. (Pubitemid 41291138)
17. Prendergast GC, Lawe D, Ziff EB. 1991. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65:395-407. (Pubitemid 121002049)
18. Rahmann S, Muller T, Vingron M. 2003. On the power of profiles for transcription factor binding site detection. Stat Appl Genet Mol Biol. 2: Article7.
19. Razin A, Riggs AD. 1980. DNA methylation and gene function. Science 210:604-610.
20. Saxonov S, Berg P, Brutlag DL. 2006. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A. 103:1412-1417. (Pubitemid 43191179)
21. Wang J, Bowen NJ, Mariño-Ramírez L, Jordan IK. 2009. A c-Myc regulatory subnetwork from human transposable element sequences. Mol Biosyst. 5:1831-1839.
22. Weber M, et al. 2007. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 39:457-466. (Pubitemid 46514772)
23. Yoder JA, Walsh CP, Bestor TH. 1997. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:335-340. (Pubitemid 27309911)
24. Zeller KI, et al. 2006. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci U S A. 103:17834-17839. (Pubitemid 44852246)
25. Zemach A, Zilberman D. 2010. Evolution of eukaryotic DNA methylation and the pursuit of safer sex. Curr Biol. 20:R780-R785.
26. Zemojtel T, Kielbasa SM, Arndt PF, Chung HR, Vingron M. 2009. Methylation and deamination of CpGs generate p53-binding sites on a genomic scale. Trends Genet. 25:63-66.
27. Zhou YH, Zheng JB, Gu X, Saunders GF, Yung WK. 2002. Novel PAX6 binding sites in the human genome and the role of repetitive elements in the evolution of gene regulation. Genome Res. 12:1716-1722. (Pubitemid 35363675)